A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors

Preferentially expressed antigen in melanoma (PRAME) and prostate-specific membrane antigen (PSMA) are tumor-associated antigens implicated in cellular differentiation, genetic stability, and angiogenesis. MKC1106-PP is an immunotherapeutic regimen cotargeting PRAME and PSMA, comprised of a recombin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Weber, Jeffrey S., Vogelzang, Nicholas J., Ernstoff, Marc S., Goodman, Oscar B., Cranmer, Lee D., Marshall, John L., Miles, Sabrina, Rosario, Dar, Diamond, David C., Qiu, Zhiyong, Obrocea, Mihail, Bot, Adrian
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3709852/
https://ncbi.nlm.nih.gov/pubmed/21760528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e3182280db1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados